Published in Genome Med on November 20, 2014
Dissecting Kawasaki disease: a state-of-the-art review. Eur J Pediatr (2017) 0.92
Kawasaki disease: a matter of innate immunity. Clin Exp Immunol (2016) 0.77
Rationale and study design for a phase I/IIa trial of anakinra in children with Kawasaki disease and early coronary artery abnormalities (the ANAKID trial). Contemp Clin Trials (2016) 0.77
Found in Translation: International initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki Disease. Arthritis Rheumatol (2016) 0.77
Unique Molecular Patterns Uncovered in Kawasaki Disease Patients with Elevated Serum Gamma Glutamyl Transferase Levels: Implications for Intravenous Immunoglobulin Responsiveness. PLoS One (2016) 0.77
A child with resistant Kawasaki disease successfully treated with anakinra: a case report. BMC Pediatr (2017) 0.75
Whole genome sequencing of an African American family highlights toll like receptor 6 variants in Kawasaki disease susceptibility. PLoS One (2017) 0.75
Identification of Differentially Expressed Genes in Kawasaki Disease Patients as Potential Biomarkers for IVIG Sensitivity by Bioinformatics Analysis. Pediatr Cardiol (2016) 0.75
The frontline of immune response in peripheral blood. PLoS One (2017) 0.75
Urotensin 2 in Kawasaki disease pathogenesis. Pediatr Res (2017) 0.75
A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97
The myofibroblast: one function, multiple origins. Am J Pathol (2007) 8.64
Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation (1996) 7.29
Analysis of microarray data using Z score transformation. J Mol Diagn (2003) 6.82
Formation and function of the myofibroblast during tissue repair. J Invest Dermatol (2007) 6.11
A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76
Nationwide survey of Kawasaki disease and acute rheumatic fever. J Pediatr (1991) 2.82
Application of z-score transformation to Affymetrix data. Appl Bioinformatics (2003) 2.56
Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J (1998) 2.53
Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr (2008) 2.44
Epidemiologic features of Kawasaki disease in Japan: results of the 2009-2010 nationwide survey. J Epidemiol (2012) 2.15
Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol (2005) 1.81
Restraint of inflammatory signaling by interdependent strata of negative regulatory pathways. Nat Immunol (2012) 1.49
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol (2007) 1.39
Cardiac biopsy of Kawasaki disease. Arch Pathol Lab Med (1981) 1.16
CEACAM1 (CD66a) mediates delay of spontaneous and Fas ligand-induced apoptosis in granulocytes. Eur J Immunol (2005) 1.13
Gene expression profiles in febrile children with defined viral and bacterial infection. Proc Natl Acad Sci U S A (2013) 1.11
Sustained activation of neutrophils in the course of Kawasaki disease: an association with matrix metalloproteinases. Clin Exp Immunol (2005) 1.07
Increased prevalence of atopic dermatitis in Kawasaki disease. Pediatr Infect Dis J (1988) 1.03
Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling. PLoS One (2013) 1.03
SASPase regulates stratum corneum hydration through profilaggrin-to-filaggrin processing. EMBO Mol Med (2011) 1.02
A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation. Ann Rheum Dis (2012) 0.99
Cyp26b1 regulates retinoic acid-dependent signals in T cells and its expression is inhibited by transforming growth factor-β. PLoS One (2011) 0.99
Incidence of Kawasaki disease in northern European countries. Pediatr Int (2012) 0.98
Transcriptomic profiling in childhood H1N1/09 influenza reveals reduced expression of protein synthesis genes. J Infect Dis (2013) 0.98
Identification and characterization of a novel retroviral-like aspartic protease specifically expressed in human epidermis. J Invest Dermatol (2005) 0.96
The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child (2006) 0.94
Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistance. Hum Immunol (2010) 0.93
Loss of NKX3.1 favors vascular endothelial growth factor-C expression in prostate cancer. Cancer Res (2008) 0.92
The role of TGF-β and myofibroblasts in the arteritis of Kawasaki disease. Hum Pathol (2012) 0.92
Increased risk of atopic dermatitis in preschool children with kawasaki disease: a population-based study in taiwan. Evid Based Complement Alternat Med (2013) 0.90
Label-free quantitative proteomic analysis of right ventricular remodeling in infant Tetralogy of Fallot patients. J Proteomics (2013) 0.86
CEACAM1 and the regulation of mucosal inflammation. Mucosal Immunol (2008) 0.84
Elevated granulocyte colony-stimulating factor levels predict treatment failure in patients with Kawasaki disease. J Allergy Clin Immunol (2008) 0.83
Adrenomedullin is highly expressed in blood monocytes associated with acute Kawasaki disease: a microarray gene expression study. Pediatr Res (2004) 0.82
Clinical score and transcript abundance patterns identify Kawasaki disease patients who may benefit from addition of methylprednisolone. Pediatr Res (2009) 0.81
Primary repair of tetralogy of Fallot in infants: transatrial/transpulmonary or transventricular approach. Asian J Surg (2013) 0.77